Will The High Cost Of Vertex's New Cystic Fibrosis Drug Push The U.S. To European Style Pricing?

But when true breakthroughs occur, it can be years before a competitive therapy emerges. Thus, we have the current situation of higher prices in the U.S. It is hard to envision this remaining the status quo over the next five years.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Source Type: news